Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor

被引:20
|
作者
Emani, Sirisha [1 ]
Ramlawi, Basel [1 ]
Sodha, Neel R. [1 ]
Li, Jian [1 ]
Bianchi, Cesario [1 ]
Sellke, Frank W. [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
来源
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2009年 / 138卷 / 01期
关键词
FACTOR-I; VEGF; ACTIVATION; HYPOXIA; PROLIFERATION; ANGIOGENESIS; KINASE; CELLS;
D O I
10.1016/j.jtcvs.2008.12.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several inflammatory mediators such as vascular endothelial growth factor and hepatocyte growth factor are known to play a critical role in the regulation of vascular permeability and angiogenesis. We studied the serum levels of growth factors and gene expression profiles of genes involved in growth factor signaling in the peripheral blood of patients with and patients without diabetes following cardiopulmonary bypass and cardioplegic arrest. Methods: Serum and total RNA were obtained from the blood samples collected from patients with diabetes and matched patients without diabetes (n = 7 patients each) who had coronary artery bypass graft before and 6 hours and 4 days after cardiopulmonary bypass/cardioplegic arrest. The cytokine panel, consisting of growth factors such as vascular endothelial growth factor, hepatocyte growth factor, fibroblast growth factor, and epidermal growth factor, was quantified in patients with diabetes and patients without diabetes before and 6 hours and 4 days post-cardiopulmonary bypass/cardioplegic arrest using multiplex cytokine quantification system. cDNA microarray analysis was performed and fold-change was calculated. Results: Length of hospitalization (10 vs 6 days; P = .04) and weight gain (5 vs 2.5 kg; P = .001) were significantly greater for patients with diabetes compared with patients without diabetes. The serum levels of vascular endothelial growth factor and hepatocyte growth factor were significantly elevated in patients with diabetes when compared with patients without diabetes before versus 6 hours post-cardiopulmonary bypass/cardioplegic arrest. In addition, significantly elevated mRNA expression of hypoxia-inducible factor-1 alpha, cyclic adenosine monophosphate response element binding protein, and E1A binding protein p300 (more than twofold) was observed 4 days post-cardiopulmonary bypass/cardioplegic arrest exclusively in patients with diabetes. Conclusions: The differential profile of gene and protein expression of growth factors and their related genes in patients with diabetes and patients without diabetes could be associated with increased edema and weight gain in patients with diabetes after cardiopulmonary bypass/cardioplegic arrest.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 50 条
  • [21] Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1?
    Peng Xuebing
    Li TinChiu
    Xia Enlan
    Luo Jing
    Huang Xiaowu
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2011, 159 (01) : 198 - 203
  • [22] Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of patients with myeloproliferative disorders (MPD)
    Wróbel, T
    Mazur, G
    Surowiak, P
    Wolowiec, D
    Jelen, M
    Kuliczkowski, K
    PATHOLOGY & ONCOLOGY RESEARCH, 2003, 9 (03) : 170 - 173
  • [23] Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization
    Wang, B.
    Xu, H.
    Gao, Z. Q.
    Ning, H. F.
    Sun, Y. Q.
    Cao, G. W.
    ACTA RADIOLOGICA, 2008, 49 (05) : 523 - 529
  • [24] Increased expression of vascular endothelial growth factor-a in seasonal allergic rhinitis
    Benson, M
    Carlsson, B
    Carlsson, LMS
    Wennergren, G
    Cardell, LO
    CYTOKINE, 2002, 20 (06) : 268 - 273
  • [25] Increased vascular endothelial growth factor expression in human hearts with microvascular fibrin
    Torry, RJ
    Bai, L
    Miller, SJ
    Labarrere, CA
    Nelson, D
    Torry, DS
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (01) : 175 - 184
  • [26] Plasmablastic multiple myeloma is associated with increased vascular endothelial growth factor immunoexpression
    Ribas, C
    Colleoni, GWB
    Almeida, MSS
    Aguiar, KCC
    Silva, MRR
    Bordin, JO
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2005, 38 (11) : 1609 - 1613
  • [27] Wall discontinuities and increased expression of vascular endothelial growth factor-A and vascular endothelial growth factor receptors 1 and 2 in endometrial blood vessels of women with menorrhagia
    Mints, Miriam
    Hultenby, Kjell
    Zetterberg, Eva
    Blomgren, Bo
    Falconer, Christian
    Rogers, Rick
    Palmblad, Jan
    FERTILITY AND STERILITY, 2007, 88 (03) : 691 - 697
  • [28] Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast
    Guidi, AJ
    Schnitt, SJ
    Fischer, L
    Tognazzi, K
    Harris, JR
    Dvorak, HF
    Brown, LF
    CANCER, 1997, 80 (10) : 1945 - 1953
  • [29] Increased serum levels of vascular endothelial growth factor in pemphigus foliaceus patients with erythroderma
    Miyamoto, D.
    Sotto, M. N.
    Otani, C. S. V.
    Fukumori, L. M. I.
    Pereira, N. V.
    Santi, C. G.
    Maruta, C. W.
    Burnier, M. N. N.
    Rebeis, M. M.
    Aoki, V.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (02) : 333 - 336
  • [30] Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma
    Guidi, AJ
    AbuJawdeh, G
    Tognazzi, K
    Dvorak, HF
    Brown, LF
    CANCER, 1996, 78 (03) : 454 - 460